Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 22, 2012 12:30 ET | Source: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals announces financial results for the first half 2012, anticipated financing, revised EU regulatory filing strategy and revised outlook for 2012.

Company Announcement no. 11/2012 To: NASDAQ OMX Copenhagen...
August 22, 2012 12:30 ET | Source: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals offentliggør finansielt resultat for første halvår 2012, forventet finansiering, revideret regulatorisk indsendelsesstrategi i EU og opdaterede forventninger til 2012.

Selskabsmeddelelse nr. 11/2012 Til: NASDAQ OMX Copenhagen...
August 17, 2012 06:03 ET | Source: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals A/S er vært for en telekonference i forbindelse med offentliggørelsen af kvartalsrapporten for 2. kvartal 2012

Investor service meddelelse nr. 1/2011 Til: NASDAQ OMX København ...
August 17, 2012 06:03 ET | Source: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals A/S to Host Conference Call Announcing Interim Report for second Quarter 2012

Investor service announcement no. 1/2012 To: NASDAQ OMX Copenhagen ...
May 31, 2012 09:52 ET | Source: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals to Present Results from a Patient Subgroup Analysis of Once-Daily LCP-Tacro™ in Stable African-American Kidney Transplant Patients at American Transplant Congress (ATC)

Company Announcement no. 10/2012 To: NASDAQ OMX Copenhagen...
May 31, 2012 09:52 ET | Source: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals præsenterer på American Transplant Congress (ATC)

Selskabsmeddelelse nr. 10/2012 Til: NASDAQ OMX Copenhagen...
May 23, 2012 04:40 ET | Source: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals announces a restructuring of the company to support and strengthen strategic focus on LCP-Tacro™ and announces changes to management

Company Announcement no. 9/2012 To: NASDAQ OMX Copenhagen...
May 23, 2012 04:40 ET | Source: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals A/S omstrukturerer selskabet for at understøtte og styrke det strategiske fokus på LCP-Tacro™ og offentliggør ændringer i ledelsen

Selskabsmeddelelse nr. 9/2012 Til: NASDAQ OMX Copenhagen...
May 22, 2012 09:15 ET | Source: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals A/S - Gennemførelse af kapitalnedsættelse vedtaget på ordinær generalforsamling den 18. april 2012 - opdaterede vedtægter.

Selskabsmeddelelse nr. 8/2012 Til: NASDAQ OMX Copenhagen...
May 22, 2012 09:15 ET | Source: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals A/S - Completion of the share capital reduction adopted at the ordinary general meeting on 18 April 2012 - updated articles of association.

Company Announcement no. 8/2012 To: NASDAQ OMX Copenhagen...